CASEY WOODSON: Open Payments
NPI 1356179329 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$407 in 10 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $51 · 2025 $407
Food & beverage: $407
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 1 | $140 |
| Fresenius USA Marketing, Inc. | 1 | $96 |
| Travere Therapeutics, Inc. | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Novo Nordisk Inc | 1 | $24 |
| Amgen Inc. | 1 | $22 |
| Ardelyx, Inc. | 1 | $18 |
| Alexion Pharmaceuticals, Inc. | 1 | $18 |
Products named: TARPEYO, VELPHORO, Ozempic, LOKELMA, KRYSTEXXA, IBSRELA, ULTOMIRIS, FARXIGA.
Industry payments across NC — which companies pay providers there.
